Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Entinostat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Experimental drug boosts immunotherapy shows promise in bladder cancer study
    Experimental drug boosts immunotherapy shows promise in bladder cancer study

    16 Aug 2021

    // Emily Henderson MEDICAL-NET

    https://www.news-medical.net/news/20210816/Experimental-drug-and-immunotherapy-combination-shows-promise-in-bladder-cancer-study.aspx

    Emily Henderson MEDICAL-NET
    16 Aug 2021
    Share Share
    Xynomic preps broad push for HDAC cancer drug
    Xynomic preps broad push for HDAC cancer drug

    01 Jun 2018

    // Phil Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/xynomic-preps-broad-push-for-hdac-cancer-drug-after-series-b

    Phil Taylor FIERCE BIOTECH
    01 Jun 2018
    Share Share
    Syndax pals up with Nektar on entinostat combo trial
    Syndax pals up with Nektar on entinostat combo trial

    31 May 2018

    // Phil Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/despite-asco-wobble-syndax-pals-up-nektar-entinostat-combo-trial

    Phil Taylor FIERCE BIOTECH
    31 May 2018
    Share Share
    Setback for during the ASCO preview as lead drug study fails
    Setback for during the ASCO preview as lead drug study fails

    18 May 2018

    // John Carroll ENDPTS

    https://endpts.com/syndax-is-hit-with-a-setback-during-the-asco-preview-round-as-lead-drug-flops-in-mid-stage-study/

    John Carroll ENDPTS
    18 May 2018
    Share Share
    Syndax adds Genentech PD-L1 'atezo' combo pact to its growing pipeline
    Syndax adds Genentech PD-L1 'atezo' combo pact to its growing pipeline

    27 Aug 2015

    // John Carroll FIERCE BIOTECH

    http://www.fiercebiotech.com/story/syndax-adds-genentech-pd-l1-atezo-combo-pact-its-growing-pipeline/2015-08-27

    John Carroll FIERCE BIOTECH
    27 Aug 2015
    Share Share
    Merck ties up with tiny Syndax on a 'breakthrough' cancer combo
    Merck ties up with tiny Syndax on a 'breakthrough' cancer combo

    01 Apr 2015

    // John Carroll FIERCE BIOTECH

    http://www.fiercebiotech.com/story/merck-ties-tiny-syndax-breakthrough-cancer-combo/2015-03-31

    John Carroll FIERCE BIOTECH
    01 Apr 2015
    Share Share